1. Home
  2. ALT vs ARL Comparison

ALT vs ARL Comparison

Compare ALT & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • ARL
  • Stock Information
  • Founded
  • ALT 1997
  • ARL 1999
  • Country
  • ALT United States
  • ARL United States
  • Employees
  • ALT N/A
  • ARL N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • ARL Building operators
  • Sector
  • ALT Health Care
  • ARL Real Estate
  • Exchange
  • ALT Nasdaq
  • ARL Nasdaq
  • Market Cap
  • ALT 327.4M
  • ARL 262.8M
  • IPO Year
  • ALT N/A
  • ARL N/A
  • Fundamental
  • Price
  • ALT $3.87
  • ARL $16.16
  • Analyst Decision
  • ALT Strong Buy
  • ARL
  • Analyst Count
  • ALT 6
  • ARL 0
  • Target Price
  • ALT $17.40
  • ARL N/A
  • AVG Volume (30 Days)
  • ALT 2.5M
  • ARL 1.8K
  • Earning Date
  • ALT 11-11-2025
  • ARL 11-06-2025
  • Dividend Yield
  • ALT N/A
  • ARL N/A
  • EPS Growth
  • ALT N/A
  • ARL N/A
  • EPS
  • ALT N/A
  • ARL N/A
  • Revenue
  • ALT $20,000.00
  • ARL $48,139,000.00
  • Revenue This Year
  • ALT N/A
  • ARL N/A
  • Revenue Next Year
  • ALT $761,880.20
  • ARL N/A
  • P/E Ratio
  • ALT N/A
  • ARL N/A
  • Revenue Growth
  • ALT N/A
  • ARL N/A
  • 52 Week Low
  • ALT $2.90
  • ARL $9.43
  • 52 Week High
  • ALT $11.16
  • ARL $18.28
  • Technical
  • Relative Strength Index (RSI)
  • ALT 55.49
  • ARL 58.72
  • Support Level
  • ALT $3.56
  • ARL $15.96
  • Resistance Level
  • ALT $3.72
  • ARL $17.00
  • Average True Range (ATR)
  • ALT 0.18
  • ARL 0.26
  • MACD
  • ALT 0.03
  • ARL -0.02
  • Stochastic Oscillator
  • ALT 51.15
  • ARL 55.32

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: